| 29 |
지질/비만 |
Risk of diabetes in patients treated with HMG-CoA reductase inhibitors
HMG-CoA reductase inhibitor로 치료받은 환자들에서 당뇨병 발생의 위험
Metabolism 2015;64: 482-488
|
| 28 |
뇌하수체/부신 |
쿠싱증후군의 치료 : 미국내분비학회 임상진료권고안
Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline.
J Clin Endocrinol Metab. 2015 Aug;100(8):2807-31.
|
| 27 |
뇌하수체/부신 |
말단비대증의 구조적 기능적 분류 (A Structural and Functional Acromegaly Classification)
(J Clin Endocrinol Metab 100: 122–131, 2015)
|
| 26 |
당뇨병 |
성인 제1형 당뇨병에서의 저혈당 치료를 위한 비강내 글루카곤 투여
(Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority Study)
Michael R. Rickels et al.
Diabetes Care published ahead of print December 17, 2015
|
| 25 |
당뇨병 |
새로운 인슐린 전달 시스템
Patch의 microneedle내 저산소에 민감한 vesicle에 탑재한 인슐린이 고혈당에 반응하여 빠르게 전달(Microneedle-array patches loaded with hypoxia-sensitive vesicles provide fast glucose-responsive insulin delivery)
Jicheng Yu et al.
PNAS | July 7, 2015 | vol. 112 | no. 27 8260-8265
|
| 24 |
골대사 |
산모의 혈중 비타민D농도가 자녀의 골량에 미치는 영향
Maternal Vitamin D status During Pregnancy and Bone Mass in Offspring at 20 Years of Age: A Prospective Cohort Study
J Bone Miner Res. 2014;29(5):1088-95
|
| 23 |
골대사 |
혈관 및 판막의 석회화와 수질 및 피질골의 골밀도의 상관성
QCT Volumetric Bone Mineral Density and Vascular and Valvular Calcification: The Framingham Study
Jimmy J Chan,1 L Adrienne Cupples,2,3 Douglas P Kiel,4,5,6 Christopher J O’Donnell,3,4,7 Udo Hoffmann,4,7 and Elizabeth J Samelson4,5,6 1 Albert Einstein College of Medicine, Bronx, NY, USA 2 Boston University School of Public Health, Boston, MA, USA 3 National Heart, Lung, and Blood Institute’s Framingham Heart Study, Framingham, MA, USA 4 Harvard Medical School, Boston, MA, USA 5 Institute for Aging Research, Hebrew SeniorLife, Boston, MA USA 6 Beth Israel Deaconess Medical Center, Boston, MA, USA 7 Massachusetts General Hospital, Boston, MA, USA
J Bone Miner Res 2015 Oct;30(10):1767-74
|
| 22 |
갑상선 |
재발한 그레이브스 병 환자에서 방사성 동위원소 치료와 장기간 저용량 메티마졸 치료의 임상 경과 (Outcomes in relapsed Graves’ disease patients following radioiodine or prolonged low dose of methimazole treatment)
Thyroid 2015;25(12):1282-1290
|
LOGIN
JOIN
English
